Literature DB >> 9462212

Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.

I B Autenrieth1, N Bucheler, E Bohn, G Heinze, I Horak.   

Abstract

BACKGROUND: Mice deficient in interleukin-2 (IL-2) develop inflammatory bowel disease resembling ulcerative colitis in humans. Recent studies provided evidence that alpha beta T cells, particularly CD4 T cells, rather than B cells, are involved in the pathogenesis of bowel inflammation of IL-2 deficient mice. AIM: To analyse the pattern of expression of cytokine mRNA in intestinal tissue of normal and IL-2 deficient mice.
METHODS: Expression of beta-actin, IL-1 alpha, IL-1 beta, IL-6, IL-10, tumour necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma) and transforming growth factor beta 1 (TGF-beta 1) mRNA was analysed in colon and small intestinal tissue of both IL-2 deficient (IL-2-/-) mice and normal (wild type) litter mates (IL-2+/+) at different ages by using qualitative, as well as semiquantitative, competitive reverse transcription polymerase chain reaction (RT-PCR). Results were correlated with the phase of progression of the disease, as determined by histology.
RESULTS: IL-2-/- mice had expressed low levels of IL-1 alpha, IL-1 beta, IL-6, TNF-alpha, and IFN-gamma mRNA in the colon by 1.5 weeks of age. In advance of the development of histologically and clinically detectable bowel inflammation, expression of IL-1 alpha, IL-1 beta, IL-6, TNF-alpha, IFN-gamma, and IL-10, but not TGF-beta 1, mRNA increased in the colon of IL-2 deficient mice. In contrast, IL-2+/+ mice expressed TGF-beta 1 mRNA in colon tissue at 13 and 23 weeks of age, but not IL-1 alpha, IL-1 beta, IL-6, TNF-alpha, IL-10, or IFN-gamma mRNA. Levels of expression of cytokine mRNA in tissue from the small intestine were comparable in IL-2-/- and IL-2+/+ mice.
CONCLUSIONS: Bowel inflammation in IL-2 deficient mice is preceded by an increase in IL-1 alpha, IL-1 beta, TNF-alpha, and IFN-gamma mRNA expression in colon tissue. Low levels of TGF-beta 1, but high levels of IL-1 alpha, IL-1 beta, IL-6, TNF-alpha, IFN-gamma, and IL-10 mRNA expression correlate with the manifestation of severe colitis, and suggest that T cells and macrophages are involved in bowel inflammation of IL-2 deficient mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462212      PMCID: PMC1891612          DOI: 10.1136/gut.41.6.793

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  54 in total

1.  Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis.

Authors:  G E Mullin; A J Lazenby; M L Harris; T M Bayless; S P James
Journal:  Gastroenterology       Date:  1992-05       Impact factor: 22.682

2.  Induction and prevention of colonic inflammation in IL-2-deficient mice.

Authors:  R O Ehrhardt; B R Lúdvíksson; B Gray; M Neurath; W Strober
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

3.  Functional interleukin-2 receptors on intestinal epithelial cells.

Authors:  C Ciacci; Y R Mahida; A Dignass; M Koizumi; D K Podolsky
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients.

Authors:  R P McCabe; H Secrist; M Botney; M Egan; M G Peters
Journal:  Clin Immunol Immunopathol       Date:  1993-01

5.  Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity.

Authors:  S Ehlers; M E Mielke; T Blankenstein; H Hahn
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

6.  Tumor necrosis factor-alpha gene expression in the tissues of normal mice.

Authors:  J S Hunt; H L Chen; X L Hu; T Y Chen; D C Morrison
Journal:  Cytokine       Date:  1992-09       Impact factor: 3.861

7.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

8.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

Authors:  A B Kulkarni; C G Huh; D Becker; A Geiser; M Lyght; K C Flanders; A B Roberts; M B Sporn; J M Ward; S Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 9.  Interleukin-2.

Authors:  K A Smith
Journal:  Curr Opin Immunol       Date:  1992-06       Impact factor: 7.486

10.  Immunohistological characterization of the cellular immune response against Yersinia enterocolitica in mice: evidence for the involvement of T lymphocytes.

Authors:  I B Autenrieth; P Hantschmann; B Heymer; J Heesemann
Journal:  Immunobiology       Date:  1993-01       Impact factor: 3.144

View more
  18 in total

1.  miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses.

Authors:  Udai P Singh; Angela E Murphy; Reilly T Enos; Haidar A Shamran; Narendra P Singh; Honbing Guan; Venkatesh L Hegde; Daping Fan; Robert L Price; Dennis D Taub; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

2.  Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production.

Authors:  M Waidmann; Y Allemand; J Lehmann; S di Genaro; N Bücheler; A Hamann; I B Autenrieth
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

3.  An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis.

Authors:  Jessica D Abron; Narendra P Singh; Manoj K Mishra; Robert L Price; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-04-19       Impact factor: 4.052

4.  Cytokine gene expression during postnatal small intestinal development: regulation by glucocorticoids.

Authors:  C Schaeffer; M Diab-Assef; M Plateroti; F Laurent-Huck; J M Reimund; M Kedinger; C Foltzer-Jourdainne
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

5.  Anti-inflammatory and Immunomodulatory Potency of Selenium-Enriched Probiotic Mutants in Mice with Induced Ulcerative Colitis.

Authors:  Abd El-Nasser Khattab; Ahmed M Darwish; Sarah I Othman; Ahmed A Allam; Haifa A Alqhtani
Journal:  Biol Trace Elem Res       Date:  2022-02-21       Impact factor: 3.738

6.  Effect of route of infection on outcome of Toxoplasma gondii infection in hu-PBL SCID mice.

Authors:  Desiree J Meyer; Jane E Allan; Miles H Beaman
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

7.  Leptin antagonist ameliorates chronic colitis in IL-10⁻/⁻ mice.

Authors:  Udai P Singh; Narendra P Singh; Hongbing Guan; Brandon Busbee; Robert L Price; Dennis D Taub; Manoj K Mishra; Raja Fayad; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Immunobiology       Date:  2013-05-13       Impact factor: 3.144

8.  Intestinal infection with Trichinella spiralis induces distinct, regional immune responses.

Authors:  L K Blum; S Mohanan; M V Fabre; R E Yafawi; J A Appleton
Journal:  Vet Parasitol       Date:  2013-02-05       Impact factor: 2.738

9.  An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice.

Authors:  M Schuppler; K Lötzsch; M Waidmann; I B Autenrieth
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Interferon gamma downregulates IL-8 production in primary human colonic epithelial cells without induction of apoptosis.

Authors:  K Schlottmann; F-P Wachs; J Grossmann; D Vogl; M Maendel; W Falk; J Schölmerich; T Andus; G Rogler
Journal:  Int J Colorectal Dis       Date:  2004-02-21       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.